Overview A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). Status: Completed Trial end date: 2011-03-01 Target enrollment: Participant gender: Summary This is a study to evaluate the safety and efficacy of IPX066 in advanced Parkinson's disease. Phase: Phase 3 Details Lead Sponsor: IMPAX Laboratories, Inc.Impax Laboratories, LLCTreatments: CarbidopaCarbidopa, levodopa drug combinationLevodopa